These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Immune responses to intestinal parasites: protection, pathology and prophylaxis. Wakelin D Parassitologia; 1997 Dec; 39(4):269-74. PubMed ID: 9802078 [TBL] [Abstract][Full Text] [Related]
26. [Classic strategies for diagnosis of cryptosporidiosis in patients with AIDS and chronic diarrhea]. Velásquez JN; Carnevale S; Corti M; Di Risio C; Bramajo J; Pinto M; Labbé JH; Chertcoff A; Cabrera M; Rodríguez M; Guarnera EA Acta Gastroenterol Latinoam; 1997; 27(3):107-11. PubMed ID: 9412138 [TBL] [Abstract][Full Text] [Related]
27. [Intestinal humoral immunity and digestive opportunistic infections associated with AIDS]. Meillet D; Kapel N; Favennec L; Raichvarg D; Savel J; Gobert JG C R Seances Soc Biol Fil; 1991; 185(1-2):63-8. PubMed ID: 1799883 [TBL] [Abstract][Full Text] [Related]
28. Cryptosporidiosis in immunocompromised patients in the Islamic Republic of Iran. Nahrevanian H; Assmar M J Microbiol Immunol Infect; 2008 Feb; 41(1):74-7. PubMed ID: 18327430 [TBL] [Abstract][Full Text] [Related]
29. Interferon-gamma expression in jejunal biopsies in experimental human cryptosporidiosis correlates with prior sensitization and control of oocyst excretion. White AC; Robinson P; Okhuysen PC; Lewis DE; Shahab I; Lahoti S; DuPont HL; Chappell CL J Infect Dis; 2000 Feb; 181(2):701-9. PubMed ID: 10669358 [TBL] [Abstract][Full Text] [Related]
31. Innate and cell-mediated immune responses to Cryptosporidium parvum. Theodos CM Adv Parasitol; 1998; 40():87-119. PubMed ID: 9554071 [TBL] [Abstract][Full Text] [Related]
32. Characterization of a single dose methylprednisolone acetate immune suppression model using Cryptosporidium muris and Cryptosporidium parvum. Miller TA; Schaefer FW Vet Parasitol; 2006 Oct; 141(1-2):66-83. PubMed ID: 16757117 [TBL] [Abstract][Full Text] [Related]
33. Cryptosporidiosis and the pathogenesis of AIDS-cholangiopathy. Chen XM; LaRusso NF Semin Liver Dis; 2002 Aug; 22(3):277-89. PubMed ID: 12360421 [TBL] [Abstract][Full Text] [Related]
34. Chemically and genetically immunocompromised mice are not more susceptible than immunocompetent mice to infection with Cryptosporidium muris. Miller TA; Ware MW; Wymer LJ; Schaefer FW Vet Parasitol; 2007 Jan; 143(2):99-105. PubMed ID: 16962704 [TBL] [Abstract][Full Text] [Related]
35. Gamma interferon-independent effects of interleukin-12 on immunity to Salmonella enterica serovar Typhimurium. Price JD; Simpfendorfer KR; Mantena RR; Holden J; Heath WR; van Rooijen N; Strugnell RA; Wijburg OL Infect Immun; 2007 Dec; 75(12):5753-62. PubMed ID: 17875635 [TBL] [Abstract][Full Text] [Related]
36. Comprehensive phenotypic analysis of the gut intra-epithelial lymphocyte compartment: perturbations induced by acute reovirus 1/L infection of the gastrointestinal tract. Bharhani MS; Grewal JS; Peppler R; Enockson C; London L; London SD Int Immunol; 2007 Apr; 19(4):567-79. PubMed ID: 17369189 [TBL] [Abstract][Full Text] [Related]
37. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals. Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020 [TBL] [Abstract][Full Text] [Related]
38. Dysregulation of interferon-gamma-mediated signalling pathway in intestinal epithelial cells by Cryptosporidium parvum infection. Choudhry N; Korbel DS; Edwards LA; Bajaj-Elliott M; McDonald V Cell Microbiol; 2009 Sep; 11(9):1354-64. PubMed ID: 19473199 [TBL] [Abstract][Full Text] [Related]
39. Fish immunity and parasite infections: from innate immunity to immunoprophylactic prospects. Alvarez-Pellitero P Vet Immunol Immunopathol; 2008 Dec; 126(3-4):171-98. PubMed ID: 18783835 [TBL] [Abstract][Full Text] [Related]
40. Opportunistic parasitic infections of the intestinal tract in the era of highly active antiretroviral therapy: is the CD4(+) count so important? Maggi P; Larocca AM; Ladisa N; Carbonara S; Brandonisio O; Angarano G; Pastore G Clin Infect Dis; 2001 Nov; 33(9):1609-11. PubMed ID: 11588705 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]